Intrexon Like a Bug Swatter, But Not At All The Food and Drug Administration says modified mosquitoes likely don't pose a threat, opening the door for field tests, the New York Times reports. Into the Zika Fray The New York Times profiles Randal Kirk, whose Intrexon bought Oxitec last summer. Intrexon Completes $230M Public Offering The firm sold 5,609,756 shares of its common stock at $41 per share. Proceeds will be used for general corporate purposes and strategic acquisitions or investments. Intrexon Prices Public Offering Targeting $200M The synthetic biology firm is offering about 4.9 million shares of its common stock at $41 per share. Intrexon to Complete Acquisition of Exemplar Genetics Intrexon seeks to buy the remaining 49 percent stake in the firm, which creates animal models of human diseases in miniature pigs. Sep 20, 2013 Intrexon's Q2 Revenues Rise Sharply as Loss Declines Sep 4, 2013 Mizuho Initiates Coverage of Intrexon with Buy Rating Aug 14, 2013 Intrexon Closes IPO Raising $184M Aug 8, 2013 Intrexon Goes Public, Shares Steeply Up on First Day of Trading Jul 30, 2013 Intrexon Prices IPO, Anticipates Net Proceeds of $113.5M Jul 9, 2013 Intrexon Files to Go Public with Stock Offering Targeting up to $125M in Proceeds May 2, 2013 Synthetic Biology Company Intrexon Raises $150M in Series F Preferred Investment Round Jan 3, 2013 Sanford-Burnham, Intrexon Strike iPSC Collaboration Jul 29, 2011 In Brief This Week: Caliper; PerkinElmer; Becton Dickinson; iGenix; Intrexon; Genedata, Takeda; EMBL-EBI May 31, 2011 Intrexon Raises $100M in Series E Round Apr 25, 2011 Intrexon Raises $66.9M Feb 1, 2011 Intrexon Buys Agarigen, Creates AgBio Division Jan 15, 2010 People in the News: Jan 15, 2010 Jan 8, 2010 Intrexon Raises $25M in Equity Financing Sep 1, 2009 Clinical Data to Get $1.5M from Sale of Non-core Assets Breaking News In Brief This Week: Illumina, Personalis, Proteomedix, and More Ancient DNA Details Population Dynamics Within Andean Tiwanaku Civilization Genomic Data Spanning 2K Years Gives Glimpse of Etruscan Origins, Population Changes People in the News: New Appointments at Hologic, Akoya Biosciences, Caris Life Sciences, More At NSGC, Genetic Counselors Address Race-Based Medicine, Ways to Change New Products Posted to GenomeWeb: Becton Dickinson, Cosmos-ID, OncoDNA, More The Scan US Booster Eligibility Decision The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions. Arizona Bill Before Judge The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction. Additional Genes Wales is rolling out new genetic testing service for cancer patients, according to BBC News. Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.